Quantcast

Industry news that matters to you.  Learn more

Archives for September 2010

Critical Health Unveils a Biomarker for Diabetic Retinopathy Progression at the EuRetina Congress in Paris

Critical Health, a provider of innovative decision support software for ophthalmology, will showcase at the EuRetina Congress in Paris, France (Booth 222B). Recently granted a European IT Excellence Award, Retmarker allows physicians to have a more precise source of information, which is not prone to errors related to the complexity in the estimations of lesion areas present in each subfield of the retinography (color fundus photograph).

NPL Scientists Improve Biomarker Detection Technique

Scientists from NPL’s Biotechnology group have developed a new strategy to enable quicker and more precise detection of biomarkers – proteins which indicate disease. The work marks a new research direction for the group, and they hope the technique is an early step towards tools to detect Alzheimer’s and cancer at the molecular level.

GeneNews Expected to Debut ColonSentry in New York by Year’s End

GeneNews is expected to debut in its ColonSentry colorectal cancer screening LDT in New York State either by the end of the year or within the first three months of 2011, according to an equities analyst.

Reni Benjamin of Rodman & Renshaw on Tuesday said GeneNews’s R&D partner Enzo Biochem’s clinical lab division has finished validating the PCR-based test, and is about to submit the final data package to state regulators.

Asuragen Adds KRAS, BRAF Testing for Personalised Med

Asuragen is introducing KRAS and BRAF mutational testing services to support development of personalised colorectal cancer treatments.